bosentan anhydrous has been researched along with Complication, Postoperative in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, C; Liu, J; Wu, Y; Zhang, R; Zhao, M | 1 |
| Huang, C; Lu, T; Tang, M; Wu, Z | 1 |
| Goldberg, DJ; Paridon, SM | 1 |
| Hanseus, K; Hebert, A; Idorn, L; Jensen, AS; Mikkelsen, UR; Nagy, E; Søndergaard, L; Sørensen, KE; Thilen, U | 1 |
| Fujino, T; Hatano, M; Imamura, T; Inaba, T; Kinugawa, K; Komuro, I; Maki, H; Minatsuki, S; Muraoka, H; Nagai, R; Ono, M; Yao, A | 1 |
| Goldberg, DJ; Paridon, SM; Rychik, J; Snarr, BS | 1 |
| Aslaner, A; Deniz, M; Ghandour, S; Günal, O | 1 |
| Matsumura, M; Nemoto, S; Nishimura, K; Yoshimura, S | 1 |
1 review(s) available for bosentan anhydrous and Complication, Postoperative
| Article | Year |
|---|---|
Pulmonary vasodilator therapy in the failing Fontan circulation: rationale and efficacy.
Topics: Bosentan; Cardiac Output; Endothelin Receptor Antagonists; Fontan Procedure; Heart Defects, Congenital; Heart Failure; Humans; Phenylpropionates; Phosphodiesterase 5 Inhibitors; Postoperative Complications; Pulmonary Circulation; Pyridazines; Sildenafil Citrate; Sulfonamides; Vascular Resistance; Vasodilator Agents | 2015 |
2 trial(s) available for bosentan anhydrous and Complication, Postoperative
| Article | Year |
|---|---|
The efficacy of bosentan combined with vardenafil in the treatment of postoperative pulmonary hypertension in children with congenital heart disease: A protocol of randomized controlled trial.
Topics: Bosentan; Child; Drug Therapy, Combination; Endothelin Receptor Antagonists; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Phosphodiesterase 5 Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Vardenafil Dihydrochloride | 2021 |
Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) stud
Topics: Adolescent; Adult; Bosentan; Child; Child, Preschool; Double-Blind Method; Endothelin Receptor Antagonists; Exercise Tolerance; Female; Fontan Procedure; Hemodynamics; Humans; Infant; Male; Oxygen Consumption; Placebos; Postoperative Complications; Receptor, Endothelin A; Statistics, Nonparametric; Sulfonamides; Treatment Outcome; Young Adult | 2014 |
5 other study(ies) available for bosentan anhydrous and Complication, Postoperative
| Article | Year |
|---|---|
Bosentan Therapy in a Patient with Failed Fontan Procedure: A Case Report.
Topics: Bosentan; Child, Preschool; Endothelin Receptor Antagonists; Fontan Procedure; Humans; Male; Postoperative Complications; Treatment Failure; Tricuspid Atresia; Vascular Resistance | 2019 |
Fontan circulation: the search for targeted therapy.
Topics: Bosentan; Endothelin Receptor Antagonists; Exercise Tolerance; Female; Fontan Procedure; Humans; Male; Oxygen Consumption; Postoperative Complications; Sulfonamides | 2014 |
Targeted therapy is required for management of pulmonary arterial hypertension after defect closure in adult patients with atrial septal defect and associated pulmonary arterial hypertension.
Topics: Adult; Antihypertensive Agents; Atrial Septum; Bosentan; Cardiac Catheterization; Cardiac Surgical Procedures; Disease Management; Epoprostenol; Exercise Tolerance; Female; Heart Septal Defects, Atrial; Hemodynamics; Humans; Hypertension, Pulmonary; Japan; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Sulfonamides; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 2015 |
[Intestinal blood flow alterations in postoperative intraabdominal adhesion formation and the role of Endothelin-1 blockade].
Topics: Abdomen; Animals; Antihypertensive Agents; Blood Flow Velocity; Bosentan; Disease Models, Animal; Endothelin-1; Intestines; Mesenteric Arteries; Peritoneal Diseases; Postoperative Complications; Pulsatile Flow; Rats; Rats, Wistar; Sulfonamides; Tissue Adhesions | 2006 |
[An initial experience of endotherine-1 dual-receptor blockade in the treatment of sustained pulmonary hypertension early after congenital cardiac surgery in infancy].
Topics: Antihypertensive Agents; Bosentan; Endothelin A Receptor Antagonists; Female; Heart Septal Defects, Ventricular; Humans; Hypertension, Pulmonary; Infant; Postoperative Complications; Sulfonamides | 2007 |